- Home
- FMN vs JSPR Comparison
FMN vs JSPR Comparison
Compare FMN & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMN
- JSPR
- Stock Information
- Founded
- FMN 2002
- JSPR 2018
- Country
- FMN United States
- JSPR United States
- Employees
- FMN N/A
- JSPR N/A
- Industry
- FMN Investment Managers
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FMN Finance
- JSPR Health Care
- Exchange
- FMN Nasdaq
- JSPR Nasdaq
- Market Cap
- FMN 82.6M
- JSPR 85.8M
- IPO Year
- FMN N/A
- JSPR N/A
- Fundamental
- Price
- FMN $10.64
- JSPR $6.70
- Analyst Decision
- FMN
- JSPR Strong Buy
- Analyst Count
- FMN 0
- JSPR 9
- Target Price
- FMN N/A
- JSPR $59.25
- AVG Volume (30 Days)
- FMN 22.8K
- JSPR 386.0K
- Earning Date
- FMN 01-01-0001
- JSPR 08-12-2025
- Dividend Yield
- FMN 3.86%
- JSPR N/A
- EPS Growth
- FMN N/A
- JSPR N/A
- EPS
- FMN N/A
- JSPR N/A
- Revenue
- FMN N/A
- JSPR N/A
- Revenue This Year
- FMN N/A
- JSPR N/A
- Revenue Next Year
- FMN N/A
- JSPR N/A
- P/E Ratio
- FMN N/A
- JSPR N/A
- Revenue Growth
- FMN N/A
- JSPR N/A
- 52 Week Low
- FMN $9.09
- JSPR $3.13
- 52 Week High
- FMN $11.31
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- FMN 51.46
- JSPR 71.26
- Support Level
- FMN $10.55
- JSPR $5.35
- Resistance Level
- FMN $10.77
- JSPR $5.72
- Average True Range (ATR)
- FMN 0.09
- JSPR 0.53
- MACD
- FMN 0.01
- JSPR 0.11
- Stochastic Oscillator
- FMN 40.91
- JSPR 82.72
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.